Our healthcare providers work collaboratively with patients to create a comprehensive plan that includes GLP-1 medications, dietary changes, increased physical activity, and behavioral support
they are also costly and carry a risk of severe, sometimes fatal, side effects
[1-2] In clinical trials for type 2 diabetes mellitus (T2DM), cholelithiasis was reported in 1.5% of patients treated with Ozempic 0.5 mg and 0.4% of patients treated with Ozempic 1 mg subcutaneous injection
Patients may experience tingling or pins-and-needles that don't go away, burning sensations when nothing is hot, numbness in hands or feet, uncomfortable feelings when touched normally, or skin that feels wet or cold when it's not
Sharma, D., Verma, S., Vaidya, S., Kalia, K
Healthcare providers may advise weighing the potential benefits of GLP-1 drugs such as better blood sugar control and weight loss against possible unknown risks